Evidence of Gene-Gene Interaction and Age-at-Diagnosis Effects in Type 1 Diabetes

The common genetic loci that independently influence the risk of type 1 diabetes have largely been determined. Their interactions with age-at-diagnosis of type 1 diabetes, sex, or the major susceptibility locus, HLA class II, remain mostly unexplored. A large collection of more than 14,866 type 1 diabetes samples (6,750 British diabetic individuals and 8,116 affected family samples of European descent) were genotyped at 38 confirmed type 1 diabetes-associated non-HLA regions and used to test for interaction of association with age-at-diagnosis, sex, and HLA class II genotypes using regression models. The alleles that confer susceptibility to type 1 diabetes at interleukin-2 (IL-2), IL2/4q27 (rs2069763) and renalase, FAD-dependent amine oxidase (RNLS)/10q23.31 (rs10509540), were associated with a lower age-at-diagnosis (P = 4.6 × 10−6 and 2.5 × 10−5, respectively). For both loci, individuals carrying the susceptible homozygous genotype were, on average, 7.2 months younger at diagnosis than those carrying the protective homozygous genotypes. In addition to protein tyrosine phosphatase nonreceptor type 22 (PTPN22), evidence of statistical interaction between HLA class II genotypes and rs3087243 at cytotoxic T-lymphocyte antigen 4 (CTLA4)/2q33.2 was obtained (P = 7.90 × 10−5). No evidence of differential risk by sex was obtained at any loci (P ≥ 0.01). Statistical interaction effects can be detected in type 1 diabetes although they provide a relatively small contribution to our understanding of the familial clustering of the disease.

[1]  John A. Todd,et al.  Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes , 2012, Human molecular genetics.

[2]  J. Małyszko,et al.  Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. , 2011, Transplantation proceedings.

[3]  P. Bingley,et al.  Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct , 2011, Diabetes.

[4]  J. Todd,et al.  Genetic Analysis of Adult-Onset Autoimmune Diabetes , 2011, Diabetes.

[5]  P. Sham,et al.  Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.

[6]  E. Urcelay,et al.  Polymorphisms in chromosome region 12q13 and their influence on age at onset of type 1 diabetes , 2011, Diabetologia.

[7]  P. Visscher,et al.  Estimating missing heritability for disease from genome-wide association studies. , 2011, American journal of human genetics.

[8]  E. Urcelay,et al.  A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes , 2011, Immunogenetics.

[9]  J. She,et al.  Genetically Dependent ERBB3 Expression Modulates Antigen Presenting Cell Function and Type 1 Diabetes Risk , 2010, PloS one.

[10]  D. Clayton Prediction and Interaction in Complex Disease Genetics: Experience in Type 1 Diabetes , 2009, PLoS genetics.

[11]  D. Clayton,et al.  Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA‐B and HLA‐A , 2009, Diabetes, obesity & metabolism.

[12]  D. Clayton,et al.  PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes , 2008, Diabetes.

[13]  P. Njølstad,et al.  Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes , 2008, Diabetologia.

[14]  Simon C. Potter,et al.  Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A , 2007, Nature.

[15]  S. Husby,et al.  Sex‐specific association of the human PTPN22 1858T‐allele with type 1 diabetes , 2007, International journal of immunogenetics.

[16]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[17]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[18]  J. Todd,et al.  Interaction analysis of the CBLB and CTLA4 genes in type 1 diabetes , 2007, Journal of leukocyte biology.

[19]  M. Rewers,et al.  Association of the PTPN22/LYP gene with type 1 diabetes , 2006, Pediatric diabetes.

[20]  J. Ilonen,et al.  Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes , 2006, Diabetologia.

[21]  F. Pociot,et al.  CBLB variants in type 1 diabetes and their genetic interaction with CTLA4 , 2005, Journal of leukocyte biology.

[22]  Juliet M Chapman,et al.  No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. , 2005, American journal of human genetics.

[23]  Heather J Cordell,et al.  Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, gene‐gene and gene‐environment interactions, and parent‐of‐origin effects , 2004, Genetic epidemiology.

[24]  H. Erlich,et al.  Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. , 2003, American journal of human genetics.

[25]  H. Cordell Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.

[26]  C R Weinberg,et al.  Designing and analysing case-control studies to exploit independence of genotype and exposure. , 1997, Statistics in medicine.

[27]  C. Boitard,et al.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[28]  Soumitra Ghosh,et al.  Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.

[29]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[30]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .